Uncategorized - November 27, 2014
Test ID’s Antibiotic Resistance
Scientists from Uppsala University, the Science for Life Laboratory (SciLifeLab) in Stockholm and Uppsala University Hospital have developed a new method of rapidly identifying which bacteria are causing an infection and determining whether they are resistant or sensitive to antibiotics. The findings are now being published in the Journal of Clinical Microbiology. ‘Clinical use of […]
Pharma Diagnostics - November 26, 2014
Camera Scans for Arthritis
A hyperspectral camera developed by the firm Norsk Elektro Optikk is being used to scan people’s hands to try to detect arthritis in its earliest stages. Lise Randeberg, a professor in biomedical optics and photonics at the Norwegian University of Science and Technology NTNU, and her colleagues are studying small changes in light and color […]
Uncategorized - November 26, 2014
Preventing Tumor Growth
Scientists at Denmark’s University of Copenhagen Biotic Research and Innovation Centre are trying to find a way to deactivate cells called fibroblasts, which can allow a malignant tumor to change and spread throughout the body. So far scientists have been able to observe how, and under which conditions, cancer cells activate fibroblasts. Finding out how […]
In a new job - November 25, 2014
Lundbeck CEO Steps Down
Lundbeck CEO Ulf Wiinberg is out of a job after failing to follow procedures on stock ownership. Wiinberg accepted shares of Stratified Medical from its founder last year without permission, violating the company’s internal policies, according to Lundbeck. And it’s an “aggravating circumstance” that Lundbeck later invested about 19 million Danish kronor, equal to US$3.2 […]
Acquisition - November 25, 2014
AZ Plans U.S. Expansion
AstraZeneca plans to kick off a U.S. expansion anticipated to add 300 jobs so it can capitalize on a pipeline full of strong candidates, which it is counting on to help return the company to growth by 2017. “Our global biologics research and development arm, MedImmune, has a robust pipeline of more than 120 biologics, […]
Funding - November 25, 2014
Beactica Receives Grant
Beactica, the Swedish fragment-based drug discovery company, announced that it has been awarded a SEK 3.0 million grant from the Swedish Governmental Agency for Innovation Systems (VINNOVA). The grant will be used to support the development of a new epigenetic drug for treatment of cancer. The goal of Beactica’s project is to develop novel compounds for […]
